BAC
Bank of America Corporation
BAC has the edge over FNWB overall, supported by stronger modeled upside and stronger fundamentals.
FNWB
First Northwest Bancorp
FNWB's outlook is improving, though it still trails on the overall score.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
FNWB Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| N/A | |
| N/A |
FNWB's revenue and profitability are currently stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like FNWB.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
FNWB PE Valuation
FNWB has no meaningful PE right now: it lost money over the past year.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over FNWB on the outlook, with more favorable revenue expectations.
FNWB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect FNWB's earnings to grow and its profitability to improve, with its revenue holding steady.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over FNWB on earnings quality, reporting a profit while its opponent remains loss making.
FNWB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.22 | — |
| Q3 2026 | -$0.01 | +$0.82 |
| Q2 2026 | $0.16 | +$1.31 |
| Q1 2026 | $0.55 | +$2.37 |
| Q4 2025 | -$0.48 | +$0.27 |
| Q3 2025 | -$0.83 | +$0.22 |
| Q2 2025 | -$1.15 | -$0.61 |
| Q1 2025 | -$1.82 | -$1.73 |
| Q4 2024 | -$0.75 | -388% |
FNWB is still losing money, but far less than before: $0.01 per share over the past year, against $1.82 at its worst in early 2025.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over FNWB on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over FNWB on profitability, with a higher operating margin.
FNWB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $16.5M | -0.5% |
| Q2 2026 | $16.2M | -1.1% |
| Q1 2026 | $16.4M | -6.7% |
| Q4 2025 | $18.4M | +19% |
| Q3 2025 | $16.6M | +4.9% |
| Q2 2025 | $16.4M | -24% |
| Q1 2025 | $17.6M | +9.4% |
| Q4 2024 | $15.4M | +37% |
FNWB's revenue fell from its 2022 peak and has held roughly level since: $16M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -9.5% | -8.6 points |
| Q2 2026 | 2% | -22 points |
| Q1 2026 | -1.9% | +56 points |
| Q4 2025 | 5% | +21 points |
| Q3 2025 | -0.9% | +19 points |
| Q2 2025 | 24% | +37 points |
| Q1 2025 | -58% | -63 points |
| Q4 2024 | -16% | +45 points |
FNWB's operating margin was −9.5% last quarter, down 8.6 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the edge over FNWB on cash flow, with more consistent year-over-year improvement.
FNWB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.8M | -245% |
| Q2 2026 | $1.5M | -62% |
| Q1 2026 | $885K | +$22.6M |
| Q4 2025 | $10.3M | -18% |
| Q3 2025 | $4.7M | +309% |
| Q2 2025 | $4M | -51% |
| Q1 2025 | -$21.7M | -$16.8M |
| Q4 2024 | $12.5M | +501% |
FNWB's free cash flow was $6M over the past year, against −$569,000 the year before. Free cash flow isn't a meaningful measure for financial services companies like FNWB.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over FNWB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
FNWB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -26.8K shares |
| 1 year | +1% | +90.2K shares |
| 3 years | -0.3% | -31.1K shares |
| 5 years | -3.9% | -364K shares |
| Available history | -10% | -1M shares |
FNWB has 9M diluted shares, up 1% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | $1M |
| Q2 2024 | — |
| Q1 2024 | $3M |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
FNWB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -31.1x | Net Cash |
| Q2 2026 | -7.4x | Net Cash |
| Q1 2026 | -2.9x | Net Cash |
| Q1 2024 | -18.4x | Net Cash |
| Q4 2023 | 6.1x | High |
| Q3 2023 | -1.1x | Net Cash |
| Q2 2023 | -1.0x | Net Cash |
| Q1 2023 | -0.9x | Net Cash |
FNWB has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
FNWB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 20.8 | Neutral |
FNWB's weekly RSI is 45 (neutral) and its Stochastic is 21 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over FNWB on valuation relative to its sector.
FNWB PE vs Financial Services Sector
| Metric | FNWB | Sector median | Relative |
|---|---|---|---|
| PE | 64x | 13x | 391% above |
| PE % | 97 | 63 | 34 pts above |
FNWB has no meaningful PE right now: it lost money over the past year.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
FNWB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.88 | 0.4% below |
| 20 week MA | $10.7 | 7.9% below |
| 50 week MA | $10.2 | 3.1% below |
| 100 week MA | $9.66 | 1.9% above |
| 200 week MA | $11.0 | 11% below |
FNWB's trend is mixed: it's above one of its five weekly moving averages, and 11% below its 200-week average.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
FNWB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $18.0 | $15.7 | -13% |
| 2021 | $15.7 | $20.1 | +28% |
| 2022 | $20.1 | $14.5 | -28% |
| 2023 | $14.5 | $15.9 | +9.6% |
| 2024 | $15.9 | $10.2 | -36% |
| 2025 | $10.2 | $9.72 | -4.6% |
| 2026 YTD | $9.72 | $9.84 | +1.2% |
FNWB has the edge over BAC on returns for 2026, with the stronger performance.